Jasper Therapeutics Reports First Quarter 2023 Financial Results and Provides a Business Update
May 12, 2023
Jasper Therapeutics Announces Appointment of Stephen J. Galli, M.D. to Scientific Advisory Board
May 10, 2023
Jasper Therapeutics Announces Appointment of Matthew Ford as Vice President, Human Resources
April 13, 2023
Jasper Therapeutics Appoints David Hinds as Senior Vice President, Development Operations
April 10, 2023
Jasper Therapeutics to Present at Cantor Fitzgerald’s The Future of Oncology Virtual Symposium
March 31, 2023
Jasper Therapeutics Appoints Daniel Adelman, M.D., as Acting Chief Medical Officer
March 23, 2023
Jasper Therapeutics to Present at Upcoming Conferences
March 9, 2023
Jasper Therapeutics Reports Fiscal 2022 Financial Results and Provides a Business Update
March 8, 2023
Jasper Therapeutics Appoints Industry Veteran Vishal Kapoor to its Board of Directors
February 17, 2023
Jasper Therapeutics Announces Positive Follow-up Clinical Data from Investigator-Sponsored Study of Briquilimab Conditioning in Fanconi Anemia Patients at the 2023 Transplantation & Cellular Therapy Meetings of the ASTCT and CIBMTR
February 17, 2023
Displaying 11 - 20 of 31